The Race to Find the Tangier Disease Gene

For this article, Brendan A. Maher interviewed Michael R. Hayden, director and senior scientist, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Canada; Stephan Rust, cholesterol metabolism group leader at the Institut für Arterioskleroseforschung an der Westfälischen Wilhelms-Universistät; and Gerd Schmitz, a physician and director of the Institut for Clinical Chemistry and Laboratory Medicine, University Hospital, Regensburg. Data from the Web of

Written byBrendan Maher
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

One of Tangier's most striking characteristics is the dramatic deficiency of high-density lipoprotein (HDL)--the so-called good cholesterol that is believed to transport excessive cholesterol from the bloodstream and transfer it to the liver where it can be expelled. The disease--also characterized by enlarged liver and spleen, peripheral neuropathy, lipid deposits in various body parts, and premature coronary artery disease--was seen as a perfect dysfunctional model for the elusive molecular basis of reverse cholesterol transport. Further, the connection with coronary artery disease (CAD), and correlation between low HDL levels and risk for CAD meant to researchers that a better understanding of Tangier could aid in fighting heart disease, a leading killer in the civilized world.

In the late 1990s, as new methods and advanced technologies in genetics became available, researchers broke into the final stretch. A linkage study mapped the gene to 9q31 in 19982 and in June of that year, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH